Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

Boehringer Ingelheim receives orphan drug designation for volasertib in US and EU By PBR Staff Writer
Boehringer Ingelheim Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) and the European Commission for its volasertib for the treatment of acute myeloid leukemia (AML).
Drug Research > Drug Discovery & Development > News
Islet Sciences reports results from two Phase IIb clinical studies for type 2 diabetics drug By PBR Staff Writer
Islet Sciences and BHV Pharma have reported positive data from the two 12-week Phase IIb clinical studies of SGLT2 inhibitor remogliflozin etabonate in type 2 diabetics.
Drug Research > Drug Discovery & Development > News OxThera secures $10m investment to continue clinical programs By PBR Staff Writer
Swedish biopharmaceutical firm OxThera has received SEK70m ($10m) from a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, to continue its major clinical programs.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
Production of Other Recombinant Biotherapeutics
As well as our expertise in the production of antibodies, Glycotope Biotechnology is continually producing a variety of other therapeutic molecules, such as cytokines and peptide hormones.
Drug Research > Drug Discovery & Development > Products
Protein Analytical Services
For demonstration and documentation of the batch-to-batch consistency of any given biopharmaceutical material, its identity, purity, quantity, bioactivity and profile of impurities must be confirmed.
Drug Research > Drug Discovery & Development > Products
Boehringer Ingelheim receives orphan drug designation for volasertib in US and EU
By PBR Staff Writer
Boehringer Ingelheim Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) and the European Commission for its volasertib for the treatment of acute myeloid leukemia (AML).
Drug Research > Drug Discovery & Development > News
Islet Sciences reports results from two Phase IIb clinical studies for type 2 diabetics drug
By PBR Staff Writer
Islet Sciences and BHV Pharma have reported positive data from the two 12-week Phase IIb clinical studies of SGLT2 inhibitor remogliflozin etabonate in type 2 diabetics.
Drug Research > Drug Discovery & Development > News
OxThera secures $10m investment to continue clinical programs
By PBR Staff Writer
Swedish biopharmaceutical firm OxThera has received SEK70m ($10m) from a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, to continue its major clinical programs.
Drug Research > Drug Discovery & Development > News
Iconic Therapeutics raises $20m to advance clinical development of wet AMD program
Iconic Therapeutics has announced that it has successfully completed a $20m Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.
Drug Research > Drug Discovery & Development > News
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.
Drug Research > Drug Discovery & Development > Suppliers
DesignMedix gets $3m NIH grant to develop low-cost malaria drug
By PBR Staff Writer
US-based biotech startup DesignMedix has received a grant of $3m from the National Institutes of Health (NIH) to continue the development and manufacturing of a new anti-malarial drug.
Drug Research > Drug Discovery & Development > News
Transdermal Technologies
LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. We are continually developing our TTS and OTF as well as microneedle technologies.
Drug Research > Drug Discovery & Development > Products
Oral Thin Films for Drug Delivery
Oral thin films (OTF) are loaded with active substances which are used for drug delivery. They are taken orally and dissolve immediately in the mouth or are applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal tract.
Drug Research > Drug Discovery & Development > Products
View all Drug Discovery & Development news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250